Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans

E-ISSN： 1873-5592|6|6|665-682

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.6, 2005-09, pp. : 665-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance

Current Medicinal Chemistry, Vol. 24, Iss. 26, 2017-09 ,pp. : 2860-2886

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential of the Molecular Diversity of Heparin and Heparan Sulfate for Drug Development

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 7, 2003-11 ,pp. : 659-667

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Mechanism of a Novel Liver-targeting Interferon IFN-CSP Involves Liver Heparan Sulfate Proteoglycan

Current Drug Delivery, Vol. 13, Iss. 4, 2016-06 ,pp. : 528-533

Bentham Science Publishers

Access to resources Recommend Favorite

Heparan Sulphate Proteoglycans and Viral Vectors : Ally or Foe?

Current Gene Therapy, Vol. 6, Iss. 1, 2006-02 ,pp. : 35-44

Bentham Science Publishers

Access to resources Recommend Favorite

Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses

By Ferro Vito

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 965-975

Informa Healthcare

Access to resources Recommend Favorite